YES = formulary NO = non-formulary NO BENEFIT = excluded
|
|
- Jared Montgomery
- 5 years ago
- Views:
Transcription
1 Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular group of generic equivalent medicines which is reviewed and updated regularly. MRP sets a maximum reimbursable price for a list of generically similar medicines with a cost lower than that of the original medicine. There may be instances where a generic alternative costs more than the set MRP. If you opt to use the original medicine and a generic alternative is available, or you use a medicine that costs more than the MRP, you will have to pay the difference between the price of the chosen medicine and that of MRP. This formulary is effective from 1 January This formulary is subject to change without notice. ONLY the following medicine classes will be considered for Beat1 and Beat2: COX inhibitors Corticosteroid Drug modifying agent (DMARD) Folic acid Intestinal inflammatory agents YES = formulary NO = non-formulary NO BENEFIT = excluded RHEUMATOID ARTHRITIS A AZATHIOPINE AZAMUN 50MG NO YES YES AZAPRESS 50MG TAB NO YES YES AZATHIOPRINE PCH 50MG TAB NO YES YES IMURAN 50MG TAB NO YES YES ZAPRINE 50MG TAB NO YES YES B BETAMETHASONE BETANOID 0.6MG/5ML SYR NO YES YES STEROMIEN 0.6MG/5ML SYR NO YES YES C CHLOROQUINE NIVAQUINE 200MG TAB NO YES YES PLASMOQUINE 200MG CAP NO YES YES MIRQUIN SYR NO NO YES CYCLOPHOSPHAMIDE ENDOXAN 50MG TAB NO YES YES D DICLOFENAC SODIUM ADCO-DICLOFENAC 50MG TAB YES YES YES 1
2 ADCO-DICLOFENAC 25MG TAB YES YES YES A-LENNON DICLOFENAC 50MG YES YES YES DICLOHEXAL 25MG YES YES YES DICLOHEXAL 50MG YES YES YES DIFEN SR 100MG NO NO YES FORTFEN SR 100MG CAP NO NO YES MYLAN DICLOFENAC 25MG YES YES YES MYLAN DICLOFENAC 50MG YES YES YES PANAMOR 25MG TAB YES YES YES PANAMOR AT 50MG TAB YES YES YES PANAMOR SR 100MG TAB NO NO YES PANAMOR SR 75MG TAB NO NO YES SANDOZ DICLOFENAC 100SR NO NO YES SANDOZ DICLOFENAC 25 YES YES YES SANDOZ DICLOFENAC 50MG YES YES YES VELTEX 100MG CAP NO NO YES VELTEX 75MG CAP NO NO YES VOLTAREN 25MG TAB YES YES YES VOLTAREN 75MG TAB NO NO YES VOLTAREN GT 50MG TAB YES YES YES VOLTAREN SR 100MG TAB NO NO YES F FOLIC ACID AHA FOLIC ACID 5MG TAB YES YES YES BE-TABS FOLIC ACID 5MG YES YES YES FOLIC ACID 5MG TAB YES YES YES I IBUPRUFEN ADCO-IBUPROFEN 400MG TAB NO YES YES BETAGESIC 200MG TAB NO YES YES BETAPROFEN 200MG TAB NO YES YES BETAPROFEN 400 FC NO YES YES BREN 400MG TAB NO YES YES BRUFEN PAED SUSP NO YES YES IBOFLAM 200MG TAB NO YES YES 2
3 IBU 200MG TAB NO YES YES IBUGESIC 100MG/5ML SUSP NO YES YES IBUMED 200MG TAB NO YES YES IBUNATE 200MG NO YES YES INZA 200MG TAB NO YES YES INZA 400MG TAB NO YES YES LENAFEN 200MG NO YES YES NORFLAM T 200MG NO YES YES NUROFEN CAPLETS 200MG NO YES YES NUROFEN CHILDREN SUGAR FR NO YES YES NUROFEN EXTRA STRENGTH NO YES YES NUROFEN FOR CHILD STRAWBE NO YES YES NUROFEN TAB NO YES YES PAINIL 200MG TAB NO YES YES RANFEN 200MG TAB NO YES YES RANFEN 400MG TAB NO YES YES SANDOZ IBUPROFEN 200MG NO YES YES SANDOZ IBUPROFEN 400MG NO YES YES SANDOZ IBUPROFEN 600MG NO YES YES INDOMETHACIN ADCO-INDOMETHACIN 25 CAP NO YES YES ADVIL LIQUI GEL NO YES YES AMDOCIN 25MG NO YES YES ARTHREXIN 25MG CAP NO YES YES BETACIN 25MG CAP NO YES YES FLAMECID 25MG CAP NO YES YES GULF INDOMETHACIN 25MG NO YES YES MEDIFLEX 25MG CAP NO YES YES METHOCAPS 25MG NO YES YES SANDOZ INDOMETHACIN 25MG NO YES YES L LEFLUNOMIDE ARAVA 10MG NO YES YES ARAVA 20MG NO YES YES 3
4 M MELOXICAM ADCO-MELOXICAM 15MG TAB NO NO YES ADCO-MELOXICAM 7.5MG TAB NO YES YES ARROW MELOXICAM 15MG TAB NO NO YES ARROW MELOXICAM 7.5MG TAB NO YES YES ARTHROCOX 15MG TAB NO NO YES ARTHROCOX 7.5MG TAB NO YES YES COXFLAM 15MG NO NO YES COXFLAM 7.5MG NO YES YES FLAMARYX 15MG TAB NO NO YES FLAMARYX 7.5MG TAB NO YES YES FLEXOCAM 15MG TAB NO NO YES FLEXOCAM 7.5MG TAB NO YES YES LOXIFLAM 15MG NO NO YES LOXIFLAM 7.5MG NO YES YES M-CAM 15MG TAB NO NO YES M-CAM 7.5MG TAB NO YES YES MEDOXICAM 15MG TAB NO NO YES MEDOXICAM 7.5MG TAB NO YES YES MELFLAM 15MG TAB NO NO YES MELFLAM 7.5MG TAB NO YES YES MOBIC 15MG TAB NO NO YES MOBIC 7.5MG TAB NO YES YES SANDOZ MELOXICAM 7.5MG NO YES YES SANDOZ MELOXICAM 15MG NO NO YES ZYDUS-MELOXICAM 15MG TAB NO NO YES ZYDUS-MELOXICAM 7.5MG TAB NO YES YES METHOTREXATE METHOTREXATE 2.5MG TAB YES YES YES P&U METHOTREXATE 500MG NO YES YES P&U METHOTREXA 50MG/2ML NO YES YES P PREDNISONE BE-TABS PREDNISONE 5MG YES YES YES METICORTEN 5MG TAB YES YES YES 4
5 PANAFCORT 5MG TAB YES YES YES TROLIC 5MG TAB YES YES YES Q QUININE SULPHATE QUININE SULPH 300MG TAB NO BENEFIT YES YES S SULPHASALAZINE SALAZOPYRIN 500MG TAB YES YES YES SALAZOPYRIN-EN 500MG YES YES YES 5
ACNE - SEVERE. Pace4 Pace3 Pace2 Pace1 Beat 4 Beat3. Pace4 Pace3 Pace2 Pace1 Beat 4 Beat3 MEDICINE NAME MEDICINE NAME
ACNE - SEVERE Pace Beat 4 Beat3 Pace Beat 4 Beat3 A ACNETANE 0 CYCLIDOX EC 00MG CAP ACNETANE 20 CYCLIMYCIN 00MG CAP ADCO-CO-TRIMOXAZOLE CYCLIMYCIN 50MG CAP ADCO-ERYTHROMYCIN 250 CAP CYPRENE-35 ED TAB ADCO-FEM
More informationYES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 B BECLOMETHASONE BECEZE 50MCG INHALER
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationYES = formulary NO = non-formulary NO BENEFIT = excluded
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationChronic pain management options in general practice
Chronic pain management options in general practice Abstract Koch K, MBChB, Private practice general practitioner and freelance medical writer Correspondence to: Karen Koch, e-mail: karenk@vodamail.co.za
More informationYES = formulary NO = non-formulary NO BENEFIT = excluded
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationYES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationOncology supportive medicine list (formulary) 2016
Oncology supportive medicine list (formulary) 2016 Who we are Glencore Medical Scheme (referred to as 'the Scheme"), registration number 1253, is a non-profit organisation, registered with the Council
More informationOncology supportive medicine list formulary
Oncology supportive medicine list formulary Disclaimer The Bankmed Special Care Oncology Programme is governed by the Bankmed Medical Scheme Rules. The use of the benefits and programmes associated with
More informationCopyright Mediscor PBM (Pty) Ltd. This document is the property of Mediscor PBM (Pty) Ltd. Unauthorised use and distribution is prohibited.
Publication Date : 2014-07-30 Page 1 700315001 IBUCINE SUSP IBUPROFEN SUSP 100 MG/5ML ANALGESIC AND ANTIPYRETICS Y N Y 704781001 IBUGESIC 100MG/5ML SUSP IBUPROFEN SUSP 100 MG/5ML ANALGESIC AND ANTIPYRETICS
More informationGINETTE TABS MEDITRIM 480MG. Anti-Histamines Cetirizine dihydrochloride 10mg tab AUSTELL CETIRIZINE 10MG
SCRIPTPHARM RISK MANAGEMENT CHRONIC MEDICINE FORMULARY Nedgroup Traditional, Traditional plus and Platinum non-pmb Formulary CHRONIC CONDITIONS ACNE (Cystic Nodular ONLY) Acne 21 beige tabs: Cyproterone
More informationSCRIPTPHARM RISK MANAGEMENT CHRONIC MEDICINE FORMULARY Nedgroup Traditional, Comprehensive and Platinum non-pmb Formulary
SCRIPTPHARM RISK MANAGEMENT CHRONIC MEDICINE FORMULARY Nedgroup Traditional, Comprehensive and Platinum non-pmb Formulary CONDITION/ICD- 10 MAJOR DRUG CLASS GENERIC NAME TRADE NAMES NAPPI TRADE NAMES NAPPI
More informationYES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class COX-2 Inhibitors Clinical Edit Information Included in this Document COX-2 Inhibitors Celebrex Drugs requiring prior authorization:
More informationAs a result of these reviews, Discovery Health has updated its Chronic Medicine Formulary and CDA.
Dear Pharmacist Update on the CDL formulary and Chronic Drug Amount for 2017 Discovery Health reviews the Chronic Medicine Formulary and Chronic Drug Amounts (CDAs) twice a year. We do this to make sure
More informationGINETTE TABS. Acne Isotretinoin 20mg ORATANE 20MG MEDITRIM 480MG. Tetracyclines Doxycycline HCl 100mg CYCLIDOX 100MG
SCRIPTPHARM RISK MANAGEMENT CHRONIC MEDICINE FORMULARY Nedgroup Traditional, Comprehensive and Platinum non-pmb Formulary CHRONIC CONDITIONS ACNE (Cystic Nodular ONLY) Acne 21 beige tabs: Cyproterone acetate
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2014 Chronic Illness Benefit 2014 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine list (for all plan types) 4 Important information
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2014 Page 1 of 22 01/2014 Chronic Illness Benefit 2014 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine list 4 Important information
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other GOLIMUMAB SIMPONI 22533, 22536, 34697, 35001 ROUTE = SUBCUTANE. GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the request for a
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same
More informationMotohealth Custom Chronic Medicine Formulary
Motohealth Custom Chronic Medicine Formulary 2018 Chronic application forms must accompany all first-time applications. All applications MUST include valid ICD10 codes. Risk Equalisation Fund criteria
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other CERTOLIZUMAB PEGOL CIMZIA 35554 GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the request for a patient with a diagnosis of moderate
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2015 Chronic Illness Benefit 2015 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine list 4 Important information you need to
More informationCareCross Chronic Medicine Formulary
CareCross Chronic Medicine Formulary 2013 Chronic application forms must accompany all first-time applications. All applications MUST include valid ICD10 codes. Risk Equalisation Fund criteria must be
More informationHelpline No:
ARTHRITIS FOUNDATION Registered Nonprofit Organisation - No. 002-847 NPO Helpline No: 0861 30 30 30 DRUGS AND ARTHRITIS This information leaflet is published by the Arthritis Foundation as part of our
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2014 Chronic Illness Benefit 2014 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine list (for all plan types) 4 Important information
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2013 Anglovaal Chronic Illness Benefit 2013 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine formulary 4 Important information
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2013 Altron Medical Aid Chronic Illness Benefit 2013 Contents Page Explanation of terms 3 The Prescribed s medicine formulary (for all plan types) 4 Important
More informationChronic Illness Benefit medicine list (formulary) 2017
Chronic Illness Benefit medicine list (formulary) 2017 Who we are LA Health Medical Scheme (referred to as 'the Scheme ), registration number 1145, is a non-profit organisation, registered with the Council
More information10 Musculoskeletal and Joint Diseases
10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2016 Chronic Illness Benefit 2016 Important information you need to know We may change the information contained in this document from time to time. We
More information3. Did the patient show evidence of remission by week 8 of Humira Y N therapy?
09/23/2015 Prior Authorization AETA BETTER HEALTH OF MICHIGA (MEDICAID) Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationI. Mechanisms of action the role of prostaglandins a. Mediators of inflammation b. and much more
NSAID steroid update Leo Semes, OD, FAAO I. Mechanisms of action the role of prostaglandins a. Mediators of inflammation b. and much more II. Topical NSAIDS ophthalmic application III. Oral NSAIDs a. Precautions
More informationAnglovaal Group Medical Scheme Chronic Illness Benefit medicine list
Anglovaal Group Medical Scheme Chronic Illness Benefit medicine list 2012 AVGMS Chronic Illness Benefit 2012 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine formulary 4 Important
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2015 Chronic Illness Benefit 2015 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine list (for all plan types) 4 Frequently
More informationAcute Pain Guidelines
Acute Pain Guidelines This is a summary of the South African Acute Pain Guidelines which is an official publication of The South African Society of Anaesthesiologists (SASA). For a full version of this
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2017 Chronic Illness Benefit 2017 Important information you need to know The Discovery Health Medical Scheme Rules set out the requirements for the Chronic
More informationOntario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes December 2017 Effective December 21, 2017 Drug Programs Policy and Strategy Branch
More informationChronic Illness Benefit medicine list (formulary) 2016
Chronic Illness Benefit medicine list (formulary) 2016 Who we are TFG Medical Aid Scheme (referred to as 'the Scheme"), registration number 1578, is a non-profit organisation, registered with the Council
More informationChronic Illness Benefit medicine list (formulary) 2016
Chronic Illness Benefit medicine list (formulary) 2016 Who we are The Anglovaal Group Medical Scheme (referred to as the Scheme ), registration number 1571. This is a non-profit organisation, registered
More informationCYSTIC FIBROSIS. Pace4 Pace3 Pace2 A AMOXYCILLIN ADCO-AMOX 125MG SUSP YES ADCO-AMOX 500MG CAP ADCO-AMOX 250MG SUSP A-LENNON AMOXYCILLIN 250M
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationUPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Off
More informationChronic Illness Benefit medicine list (formulary) 2012
Chronic Illness Benefit medicine list (formulary) 2012 Discovery Health Chronic Illness Benefit 2012 Contents Page Explanation of terms 2 The Prescribed s medicine formulary (for all plan types) 3 Important
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2012 Discovery Health Chronic Illness Benefit 2012 Contents Page Explanation of terms 2 The Prescribed s medicine formulary (for all plan types) 3 Important
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2018 Chronic Illness Benefit 2018 Important information you need to know The Discovery Health Medical Scheme Rules set out the requirements for the Chronic
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2018 Chronic Illness Benefit 2018 Important information you need to know The Discovery Health Medical Scheme Rules set out the requirements for the Chronic
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) - 2019 Who we are Remedi Medical Aid Scheme (referred to as 'the Scheme"), registration number 1430, is a non-profit organisation, registered with the
More informationOntario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes December 2016 Effective December 22, 2016 Drug Programs Policy and Strategy Branch
More informationChanges in Benefit Status and Criteria Update: Topiramate
JANUARY 2016 Nova Scotia Formulary Updates Changes in Benefit Status and Criteria Update Topiramate Change in Benefit Status Escitalopram Criteria Update Actemra Januvia and Janumet Cimzia New Product
More informationSpecial Generic Drug Pricing Program
FREE PICK-UP & DELIVERY Flu-Shots Specialty prescription Compounding Wellness center providing health screenings for hypertension and diabetes $3 Special Generic Prescription Drug Program only offered
More informationLatest Press Release. doubledown casino active chips
corp@stantec.com Latest Press Release doubledown casino active chips S Nov 1, 2017. Ibuprofen (Advil, Motrin) and meloxicam (Mobic) are drugs used to manage mild to moderate pain, inflammation, and fever.
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC
Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 HUMIRA PEDIATRIC GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the patient currently taking Humira? If
More informationRheumatoid Arthritis
Rheumatoid Arthritis Rheumatoid Arthritis (RA) is a form of arthritis characterized by swelling and pain in the joints. If severe enough RA can also affect people s internal organs. RA is considered an
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Oral Drugs requiring prior authorization: the list of drugs requiring prior
More informationChronic Illness Benefit medicine list (formulary) 2018
Chronic Illness Benefit medicine list (formulary) 2018 Who we are Glencore Medical Scheme (referred to as 'the Scheme"), registration number 1253, is a non-profit organisation, registered with the Council
More informationChronic Illness Benefit 2018
Chronic Illness Benefit 2018 Who we are TFG Medical Aid Scheme (referred to as 'the Scheme"), registration number 1578, is a non-profit organisation, registered with the Council for Medical Schemes. Discovery
More informationChronic Illness Benefit medicine list (formulary) 2018
Chronic Illness Benefit medicine list (formulary) 2018 Who we are The Anglovaal Group Medical Scheme (referred to as the Scheme ), registration number 1571, is a nonprofit organisation, registered with
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) - 2018 Who we are Remedi Medical Aid Scheme (referred to as 'the Scheme"), registration number 1430, is a non-profit organisation, registered with the
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2012 Discovery Health Chronic Illness Benefit 2012 Contents Page Explanation of terms 2 The Prescribed s medicine formulary (for all plan types) 3 s for
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) - 2018 Who we are The BMW Employee Medical Aid Society (referred to as BEMAS ), registration number 1526, is the medical scheme that you are a member of.
More informationOntario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2017 Effective July 31, 2017 Drug Programs Policy and Strategy Branch Ontario
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2019 Chronic Illness Benefit 2019 Important information you need to know The Discovery Health Medical Scheme Rules set out the requirements for the Chronic
More informationSASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Saskatchewan Ministry of Health November 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #126 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
More informationFirst Name. Specialty: Fax. First Name DOB: Duration:
Prescriber Information Last ame: First ame DEA/PI: Specialty: Phone - - Fax - - Member Information Last ame: First ame Member ID umber DOB: - - Medication Information: Drug ame and Strength: Diagnosis:
More informationInflectra Frequently Asked Questions
Inflectra Frequently Asked Questions 1. What is the funding status of Inflectra (infliximab)? Earlier in 2016, Inflectra (infliximab) was added to the Ontario Drug Benefit (ODB) Formulary as a Limited
More informationChronic Illness Benefit medicine list (formulary)
Chronic Illness Benefit medicine list (formulary) 2013 Chronic Illness Benefit 2013 Contents Page Explanation of terms 3 The Prescribed Minimum Benefits medicine list (for all plan types) 4 Important information
More informationBirthdate: / / Address: Age: Sex: M F. Telephone: H ( ) City State Zip W ( ) C ( )
Please complete this questionnaire in its entirety, even if you feel some questions may not apply to you. Our staff is available should you have any questions, or need assistance with the completion of
More informationHundreds of Choices. More Savings Every Day. 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses
4$ Hundreds of Choices. More Savings Every Day. $ 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses EFF. DATE 09/2017 List subject to change ALLERGIES, COLD AND FLU
More informationLiterature Scan: NSAIDs
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationacute medicine formulary 2013
medihelp necesse acute medicine formulary 2013 January 2013 version 1.2013 Medihelp s Necesse acute medicine formulary Dear Doctor/Pharmacist Medihelp is pleased to present the latest updated version of
More informationHow to Make Taking Your Medications Easier
How to Make Taking Your Medications Easier Daniel Solomon, MD, MPH Candace Feldman, MD, MPH Division of Rheumatology Brigham and Women s Hospital Harvard Medical School Medications often confuse patients
More informationSpondyloarthropathies: Disease Perception Limits Market
Spondyloarthropathies: Disease Perception Limits Market Psoriatic arthritis and ankylosing spondylitis form part of the group of diseases known as the spondyloarthropathies. Psoriatic arthritis is a form
More informationDrug selection in Rheumatoid Arthritis
Drug selection in Rheumatoid Arthritis PROFESSOR KHAN ABUL KALAM AZAD PROFESSOR, DEPARTMENT OF MEDICINE DHAKA MEDICAL COLLEGE Rheumatoid arthritis Autoimmune disease Onset generally occurs between 30 and
More informationSafe Ibuprofen Dosage For Dogs
Safe Ibuprofen Dosage For Dogs how many ibuprofen can i take to overdose how many 200mg ibuprofen can i take to overdose should i take ibuprofen after a workout buy ibuprofen is ibuprofen better than acetaminophen
More informationKey words: rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, treatment access
6, 21...,.,..,..,. - (RA) -,. (AS) (PsA). (Disease-modifying antirheumatic drugs, DMARDs). DMARDs 21. - RA, AS PsA. 21. RA, DMARDs. Leflunomide (Arava)., RA Methotrexate Leflunomid. DMARDs - 5 29. - RA
More informationFml Limits. Azathioprine (Imuran) 50mg, 75mg, 100mg - $26.85 Cyclosporine, 25mg, 100mg. $ Leflunomide (Arava) 10mg Tablet - $144.
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Rheumatoid Arthritis (RA) P&T DATE: 2/15/2017 CLASS: Rheumatology/Anti-inflammatory Disorders REVIEW HISTORY 2/16, 5/15,
More informationPRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation
PRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY This audit has been designed to ensure that patients
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Celebrex) Reference Number: CP.CPA.239 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy
More informationPatient information for Oesophagoscopy
Patient information for Oesophagoscopy Full name of procedure: Rigid and flexible oesophagoscopy Short name: Oesophagoscopy or endoscopy Reason for procedure: The oesophagoscope is a telescope which can
More informationAutoimmune Diseases: Systemic and Oral Health Considerations. Ann Eshenaur Spolarich, RDH, PhD
COURSE TITLE: COURSE INSTRUCTOR: COURSE CREDITS: Autoimmune Diseases: Systemic and Oral Health Considerations JoAnn R. Gurenlian, RDH, PhD and Ann Eshenaur Spolarich, RDH, PhD 2 CEUs COURSE DATE: August
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the
More informationDosage Of Ibuprofen For 60 Pound Child
Dosage Of Ibuprofen For 60 Pound Child dosage of ibuprofen for 14 year old 600 ibuprofen dosage correct dosage of ibuprofen for dogs better fever reducer acetaminophen or ibuprofen ibuprofen buy online
More informationNew Exception Status Benefits
AUGUST 2018 Nova Scotia Formulary Updates New Exception Status Benefits Ibrance (palbociclib) Erelzi (etanercept) Criteria Updates Ciprodex (dexamethasone and ciprofloxacin) Duloxetine (Cymbalta and generic
More informationGINETTE TABS ORATANE 10MG MEDITRIM 480MG AUSTELL CETIRIZINE 10MG
SCRIPTPHARM RISK MANAGEMENT CHRONIC MEDICINE FORMULARY NEDGROUP SAVINGS PLAN CHRONIC CONDITIONS ACNE (Cystic Nodular ONLY) Acne L70.1 Acne 21 beige tabs: Cyproterone acetate 2mg; ethinylestradiol 0.035mg
More informationAd-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing)
Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March 2011 (minutes for web publishing) Ad-Hoc Rheumatology Subcommittee minutes are published in accordance with the Terms of Reference for the
More informationFDA strengthens warning that non-aspirin nonsteroidal antiinflammatory drugs (NSAIDs) can cause heart attacks or strokes
FDA strengthens warning that non-aspirin nonsteroidal antiinflammatory drugs (NSAIDs) can cause heart attacks or strokes Safety Announcement [7-9-2015] The U.S. Food and Drug Administration (FDA) is strengthening
More informationSAMPLE IgE: ESR: CRP: # Joints: %BSA: Height: Weight: BMI:
Please Note: Medical Necessity Prior Authorization may be overrided for both formulary coverage and benefit design restrictions. They are issued at the full discretion of the benefit manager. PRIOR AUTHORIZATION
More informationPatient information for Mediastinoscopy
Patient information for Mediastinoscopy Full name of procedure: Mediastinoscopy and mediastinal lymph node biopsy Short name: Mediastinoscopy Reasons for procedure: The commoner reasons for performing
More informationHome Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
More informationMEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
More information2. Does the patient have a diagnosis of giant cell arteritis (GCA)? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Actemra (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More informationClinical Policy: Certolizumab (Cimzia) Reference Number: CP.PHAR.247 Effective Date: Last Review Date: Line of Business: HIM, Medicaid
Clinical Policy: (Cimzia) Reference Number: CP.PHAR.247 Effective Date: 08.16 Last Review Date: 05.18 Line of Business: HIM, Medicaid Coding Implications Revision Log See Important Reminder at the end
More informationBENEFIT CHANGES TO NBPDP
Bulletin #789 June 15, 2010 BENEFIT CHANGES TO NBPDP This update to the New Brunswick Prescription Drug Program (NBPDP) Formulary is effective June 15, 2010. Included in this bulletin: Regular Benefit
More informationTHERAPY in RHEUMATOLOGY
THERAPY in RHEUMATOLOGY RA OA AS Systemic diseases SLE Dermatomyositis Scleroderma Gout Rheumatic fever Lyme disease RHEUMATOID ARTRHRITIS Education Build a cooperative long-term relationship Use materials
More information3. Is the prescribed dose within the Food and Drug Administration (FDA)- approved dosing for giant cell arteritis?
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Actemra (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationScottish Medicines Consortium
Scottish Medicines Consortium ketoprofen/, 100mg/20mg; 200mg/20mg modified release capsules (Axorid ) No. (606/10) Meda Pharmaceuticals 05 February 2010 The Scottish Medicines Consortium (SMC) has completed
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Duexis) Reference Number: CP.PMN.120 Effective Date: 06.01.18 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationDrug Class Review Nonsteroidal Antiinflammatory Drugs (NSAIDs)
Drug Class Review Nonsteroidal Antiinflammatory Drugs (NSAIDs) Final Update 4 Report November 2010 The purpose of the is to summarize key information contained in the Drug Effectiveness Review Project
More informationNB Drug Plans Formulary Update
Bulletin #915 October 30, 2015 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products
More information2. Is the patient responding to Remicade therapy? Y N
09/29/2015 Prior Authorization AETA BETTER HEALTH OF MICHIGA (MEDICAID) Remicade (MI88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More information